Skin cancers

Qld study: statin users have lower rate of melanoma recurrence

Long-term statin use, commenced before the diagnosis of localised melanoma, appears to protect patients from recurrence, especially in males and patients with ulcerated tumours.  In a study of 700 Queenslanders with tumour stage T1b-T4b melanoma diagnosed between 2010 and 2014, 13% developed a recurrence within two years. Long-term statin users were found to have a ...

Already a member?

Login to keep reading.

© 2022 the limbic